Electromed Stock Today

ELMD Stock  USD 31.06  0.57  1.87%   

Performance

29 of 100

 
Weak
 
Strong
Strong

Odds Of Distress

Less than 3

 
High
 
Low
Very Low
Electromed is trading at 31.06 as of the 28th of November 2024, a 1.87 percent increase since the beginning of the trading day. The stock's lowest day price was 29.9. Electromed has a very small chance of experiencing financial distress in the next few years and had a strong performance during the last 90 days. Equity ratings for Electromed are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of December 2022 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
13th of August 2010
Category
Healthcare
Classification
Health Care
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of various ages in the United States and internationally. The company has 8.46 M outstanding shares of which 145.28 K shares are currently shorted by private and institutional investors with about 2.66 trading days to cover. More on Electromed

Moving together with Electromed Stock

  0.78VREX Varex Imaging CorpPairCorr

Moving against Electromed Stock

  0.91GCTK GlucoTrackPairCorr
  0.88ZJYL JIN MEDICAL INTERNATIONALPairCorr
  0.87ELV Elevance Health Fiscal Year End 22nd of January 2025 PairCorr
  0.85TFX Teleflex IncorporatedPairCorr
  0.84CNC Centene Corp Sell-off TrendPairCorr
  0.83MASS 908 DevicesPairCorr

Electromed Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO and President and DirectorKathleen Skarvan
Thematic IdeaMedical Equipment (View all Themes)
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.821.0475
Significantly Down
Very volatile
Gross Profit Margin0.60.7626
Significantly Down
Very volatile
Total Current Liabilities4.5 M7.7 M
Way Down
Slightly volatile
Total Assets28.3 M52.2 M
Way Down
Slightly volatile
Total Current Assets22.7 M44.2 M
Way Down
Slightly volatile
Debt Levels
Electromed can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Electromed's financial leverage. It provides some insight into what part of Electromed's total assets is financed by creditors.
Liquidity
Electromed currently holds 87 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Electromed has a current ratio of 4.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Electromed's use of debt, we should always consider it together with its cash and equity.

Change In Cash

9.14 Million
Electromed (ELMD) is traded on NYSE MKT Exchange in USA. It is located in 500 Sixth Avenue NW, New Prague, MN, United States, 56071 and employs 174 people. Electromed is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 257.88 M. Electromed conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 8.46 M outstanding shares of which 145.28 K shares are currently shorted by private and institutional investors with about 2.66 trading days to cover. Electromed currently holds about 8.15 M in cash with 9.07 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96.
Check Electromed Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Electromed is $257.88 Million. Electromed retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Electromed Ownership Details

Electromed Historical Income Statement

At present, Electromed's EBIT is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 781.7 K, whereas Interest Expense is forecasted to decline to about 85.2 K. View More Fundamentals

Electromed Stock Against Markets

Electromed Corporate Management

When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.809
Earnings Share
0.72
Revenue Per Share
6.39
Quarterly Revenue Growth
0.09
Return On Assets
0.0839
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.